Research Topics
| Joshua J NeumillerSummaryAffiliation: Washington State University Country: USA Publications
|
Detail Information
Publications
Incretin pharmacology: a review of the incretin effect and current incretin-based therapiesJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99210 1495, USA
Cardiovasc Hematol Agents Med Chem 10:276-88. 2012..While the potential benefits of incretin-based therapies in the arena of cardiovascular risk reduction are promising, results from ongoing outcomes-based studies will help determine the role of these agents in this setting...
Review of linagliptin for the treatment of type 2 diabetes mellitusJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, 99210 1495, USA
Clin Ther 34:993-1005. 2012....- Pharmacology, efficacy, and safety of linagliptin for the treatment of type 2 diabetes mellitusJoshua J Neumiller
College of Pharmacy, Washington State University, Spokane, WA, USA
Ann Pharmacother 46:358-67. 2012..To review the pharmacology, pharmacokinetics, and clinical efficacy and safety of linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor recently approved in the US for use as a treatment for type 2 diabetes mellitus... - A review of inhaled technosphere insulinJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA 99217, USA
Ann Pharmacother 44:1231-9. 2010..To review the pharmacology, pharmacokinetics, efficacy, safety, and clinical use of Technosphere insulin... - Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitusJoshua J Neumiller
Department of Pharmacotherapy, Washington State University, and Elder Services, Spokane, Washington 99217, USA
Pharmacotherapy 30:463-84. 2010.... - Pharmacologic management of the older patient with type 2 diabetes mellitusJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
Am J Geriatr Pharmacother 7:324-42. 2009.... - Saxagliptin: a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitusJoshua J Neumiller
Elder Services, Washington State University, 5125 North Market Street, Spokane, WA 99217, USA
Am J Health Syst Pharm 67:1515-25. 2010..The pharmacology, pharmacokinetics, efficacy, safety, and dosage and administration of saxagliptin are reviewed... - Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitorsJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, USA
J Am Pharm Assoc (2003) 49:S16-29. 2009..To review the pharmacology (absorption, metabolism, distribution, elimination, and contraindications) of incretin-based agents currently available and in regulatory review for the treatment of patients with type 2 diabetes... - Rate of obesity in U.S. ambulatory patients with diabetes mellitus: a national assessment of office-based physician visitsJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, United States
Prim Care Diabetes 3:197-9. 2009..S. National Ambulatory Medical Care Survey (NAMCS). Our findings indicate a significant proportion of U.S. ambulatory patients with DM present with obesity and greater clinical acuity than patients with DM alone... - Liraglutide: a once-daily incretin mimetic for the treatment of type 2 diabetes mellitusJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA 99217, USA
Ann Pharmacother 43:1433-44. 2009..To review the pharmacology, pharmacokinetics, efficacy, and safety of liraglutide, a glucagon-like peptide 1 (GLP-1) analog for the treatment of type 2 diabetes mellitus... - Looking to the future: focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapiesJoshua J Neumiller
PharmD, Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, 5125 North Market Street, Spokane, WA 99217, USA
Diabetes Educ 34:183-200. 2008..This article, part 3 of a 3-part series, reviews the new class of medications known as DPP-4 inhibitors as well as discusses a future buccal insulin formulation, Oral-Lyn, on the horizon for the treatment of diabetes mellitus... - Pharmacological management of glycemic control in the geriatric patient with type 2 diabetes mellitusJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elderly Services, Spokane, Washington 99217 6131, USA
Consult Pharm 24:45-63. 2009.... - Clinical pharmacology of incretin therapies for type 2 diabetes mellitus: implications for treatmentJoshua J Neumiller
College of Pharmacy, Washington State University, Spokane, Washington 99210 1495, USA
Clin Ther 33:528-76. 2011.... - Colesevelam hydrochloride for the treatment of type 2 diabetes mellitusTravis E Sonnett
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Pullman, Washington 99164 6510, USA
Clin Ther 31:245-59. 2009.... - Inhaled dry powder insulin for the treatment of diabetes mellitusStephen M Setter
Department of Pharmacotherapy, College o f Pharmacy, Washington State University, Spokane, WA 99217 6131, USA
Clin Ther 29:795-813. 2007..Inhaled dry powder insulin (IDPI) is the first inhaled insulin approved for the treatment of type 1 and type 2 diabetes mellitus (DM)... - Technosphere insulin: an inhaled prandial insulin productJoshua J Neumiller
Department of Pharmacotherapy, Washington State University, Spokane, Washington 99210 1495, USA
BioDrugs 24:165-72. 2010..Additionally, Technosphere insulin has demonstrated a favorable safety and tolerability profile in clinical studies to date... - Janumet: a combination product suitable for use in patients with Type 2 diabetesJonathan Kent Reynolds
Washington State University, College of Pharmacy, Department of Pharmacotherapy, Pullman, WA, USA
Expert Opin Investig Drugs 17:1559-65. 2008..Sitagliptin has been shown to be safe and effective at 100 mg daily doses. When given in combination with metformin the effect on glycemic control is thought to be complementary and possibly additive... - Nurse identified hospital to home medication discrepancies: implications for improving transitional careCynthia F Corbett
College of Nursing, Washington State University, Spokane, WA, USA
Geriatr Nurs 31:188-96. 2010..Medication discrepancies were identified in virtually all classes of medications, including those with high safety risks. Evidence-based best practices to reduce transition-related medication discrepancies are presented... - Effectiveness of a pharmacist-nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health careStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, USA
Am J Health Syst Pharm 66:2027-31. 2009..The effectiveness of a collaborative pharmacist-nurse intervention on resolving detected medication discrepancies as patients transitioned from hospital to home health care was evaluated... - Transitional care: exploring the home healthcare nurse's role in medication managementStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Elder Services, Spokane, Washington 99217 6131, USA
Home Healthc Nurse 30:19-26. 2012..Nurses must partner with pharmacists, physicians, and others involved with care transitions to decrease the likelihood of patients experiencing untoward health consequences associated with medications.-Eric A. ... - Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemiaMegan N Willson
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, USA
Am J Cardiovasc Drugs 10:105-8. 2010..Nevertheless, previous research suggests that there remain racial/ethnic disparities in the access to and quality of care for hyperlipidemia... - Treatment of chorea associated with Huntington's disease: focus on tetrabenazineStephen M Setter
Washington State University Elder Sevices, Spokane, Washington 99217, USA
Consult Pharm 24:524-37. 2009..Review Huntington's disease (HD) and the role of tetrabenazine (TBZ) in treating chorea associated with this disease. Discuss the pharmacology, side-effect profile, drug interactions, precautions, and contraindications of TBZ... 
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetesJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington
Diabetes Metab Syndr Obes 3:215-26. 2010..Diligent postmarketing surveillance to elucidate the risk of pancreatitis and medullary thyroid carcinoma in a heterogeneous population are likely warranted...- Screening for undiagnosed cognitive impairment in homebound older adultsStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
Consult Pharm 24:299-305. 2009..To screen for undetected cognitive impairment in homebound elders receiving home health care services... - Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitusJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington 99217, USA
Drugs 70:377-85. 2010.... - Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organismsMark W Garrison
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington 99210 1495, USA
Clin Ther 27:12-22. 2005..Tigecycline is an investigational glycylcycline antibiotic that shows promising activity against these resistant gram-positive organisms... - Clinical review of treatment options for select nonmotor symptoms of Parkinson's diseaseLindy D Wood
Elder Services, Spokane, Washington, USA
Am J Geriatr Pharmacother 8:294-315. 2010..The nonmotor symptoms of PD have the potential to be more debilitating than the motor features of the disorder... - Can a new ultra-long-acting insulin analogue improve patient care? Investigating the potential role of insulin degludecJennifer D Robinson
Department of Pharmacotherapy, Washington State University, PO Box 646710, Pullman, WA 99164 6710, USA
Drugs 72:2319-25. 2012..This article briefly reviews current evidence for the use of insulin degludec in patients with type 1 or type 2 diabetes mellitus and discusses the potential impact of this new basal insulin on clinical practice... - The Mini-Cog: a rapid dementia screening tool suitable for pharmacists' useStephen M Setter
Department of Pharmacotherapy, Colleg eof Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
Consult Pharm 22:855-61. 2007..To familiarize the consultant pharmacist with the use of the Mini-Cog as a rapid screening tool for the assessment of dementia and outline currently available evidence regarding the validity of this screening tool within the community...